Investment case for me24 Mar 2024 13:23
It's worth highlighting that the company made loss in 2023 due to some of cost that's likely to not reoccur again
1. Cyber cost
2. Business exit cost
3. Cost reduction cost
We know 1 & 2 is last we see and ended in 2023 but point 3 is something we may see in 2024.
So on point 3. The benefits far outweighes its cost. January redundancies saving £60m and further cost saving of £100m to be announced in June will have long term benefits than its cost. These cost reduction cost are one off that's likely to have long term benefits. This in turn is expected to increase margins leading to increase profitability.
So in 2025,
1. Cost reduction cost likely to drop off
2. Margine should have increased
3. Pension cost drops off
The annual report is lagging indicator and reflect the past events. Many use 'reported' figure of what actually happen 'adjusted' figure is adjusting to business exits and events. In 2024, reported figure probably more in line with adjusted figure.
If one asked a LTH here, 'business exits cost' swallowed up much of the company profits. Which has lead to headlines on how capita performed as all media would look at is bottom line figure i.e profit
Now that 'business exits cost' is last recorded in 2023 report. Profitability should increase alongside benfits of cost reduction programme filtering through plus increase in margin.
As highlighted below, capita has way underperformed to the general market sitting near 12 month low at prices seen in 1990s. The analyst have set price targets of 24p and 18p with sector perform. At 13p, we're performing below target price and also the overall sector.
A market cap of £225m on a company producing revenue of around £3b. Subtle change in margin has a huge positive benefit.
There's been number of director buys implying they see this cheap injecting confidence.
Lastly, major institutional investors haven't reduced which was confirmed by HP in the email with no TR1 since results.
I'm sure nofear would agree with above
All in my opinion. Gla